Back to results
US 2017/0304336 A1Published application
Combination
AssigneeAleksander Vladimirovich DIKOVSKIY
InventorsAlexander Vladimirovich DIKOVSKIY, Svetlana Anatoleva ZAKIROVA, Aliaksandr Viktorovich MATSIUSHONAK
Life of this patent
Estimating the term…
Abstract
A combination comprising: (a) a glycyrrhizin derivative; and (b) a hypolipidemic drug; is disclosed. Pharmaceutical compositions, kits, methods of treatment and medical uses of the combination are also disclosed.
Claims28
A combination comprising:
- (a) a glycyrrhizin derivative;
- and
- (b) a hypolipidemic drug;
- provided that:
- wherein the hypolipidemic drug is atorvastatin, the combination does not contain a molecular complex of atorvastatin and glycyrrhizic acid;
- and
- wherein the hypolipidemic drug is simvastatin, the combination does not contain a molecular complex of simvastatin and glycyrrhizic acid.
4 more elements
A pharmaceutical composition comprising:
- (a) a glycyrrhizin derivative;
- and
- (b) a hypolipidemic drug;
- provided that:
- wherein the hypolipidemic drug is atorvastatin, the composition does not contain a molecular complex of atorvastatin and glycyrrhizic acid;
- and
- wherein the hypolipidemic drug is simvastatin, the composition does not contain a molecular complex of simvastatin and glycyrrhizic acid.
4 more elements
A pharmaceutical composition comprising:
- (a) a glycyrrhizin derivative;
- and
- (b) a hypolipidemic drug;
- wherein the pharmaceutical composition is a solid pharmaceutical composition.
1 more element
A kit comprising:
- (a) a therapeutically effective amount of a glycyrrhizin derivative, and optionally a pharmaceutically acceptable carrier or diluent in a first unit dosage form;
- (b) a therapeutically effective amount of a hypolipidemic drug, and optionally a pharmaceutically acceptable carrier or diluent in a second unit dosage form;
- and
- (c) container means for containing said first and second dosage forms.
1 more element
Dependencies are inferred from the claim text.